fMRI study examines brain’s reaction to psychedelic mushrooms

People who have taken psilocybin, the compound primarily responsible for the psychedelic effects of certain mushrooms, display a similar pattern of brain activity as seen during dreams when imaged by functional MRI, according to a researchers from Imperial College London.

The study, published in Human Brain Mapping, found that under psilocybin, activity in the brain network linked to emotional thinking—including the hippocampus and anterior cingulate cortex—became more pronounced, while activity in regions linked to high-level thinking and self-consciousness became more uncoordinated.

Read more about the research at the link below:

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.